Back to trial details

Intake questionnaire

A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

Applying to SCRI Oncology Partners · Nashville, Tennessee

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with ALK-positive NSCLC?
3. Are you able to travel to Nashville for study visits?